Pharma braces for tariffs as Trump threatens to buck trade convention – POLITICO

Both the EU and the U.S. are drawing up measures to bolster their domestic drug production, but both are currently hugely reliant on Asia for medicines and their compounds, especially cheaper generics.

The U.S. has one advantage: When supply issues arise in China or India,…

Continue Reading


Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *